Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
Activities:
Research & Development
Pharmaceutical
Trending Articles
Ariceum Therapeutics' radiopharmaceutical SCLC therapeutic receives FDA Orphan Drug Designation
The therapeutic candidate will enter into Phase I/II clinical trials in Q1 of 2025, and has shown significant promise in treating aggressive cancers such as SCLC in preclinical...
Mastering modified-release performance: excipient considerations
Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic...
BioMed X and Merck successfully complete ecDNA oncology research programme
The project looked at which genes impact the prevalence of extrachromosomal DNA in cancer cells, and how ecDNA influences the adaptability of these cells
Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription
With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
Weight loss drugs boost big pharma earnings, says AvaTrade
This week pharmaceutical giants Eli Lilly and Novo Nordisk both released their financial results for the fourth quarter of 2024, showcasing major developments in their obesity...
Upcoming event
Pharma Packaging and Labelling Forum
5–6 March 2025 | Conference | San Diego, US
See all
Related Content
Drug Delivery
Sun Pharma enters definitive financial agreement with Concert
Concert stockholders will also receive a tradable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share of common stock in cash
Ingredients
Sun Pharma questions pandemic effects on business
Director has said performance reflects the impact of the global COVID-19 pandemic but vertical integration has benefitted supply chain for formulations
Finance
Sun Pharma licenses seven generics to Chinese company
China Medical System Holdings subsidiary will develop and commercialise the Indian company's seven generic products for Mainland China
Finance
Sun Pharma to operate manufacturing plants in Japan
India's drugmaker taps into dermatology market with acquisition of Japan-based Pola Pharma
Pharmaceutical
Sun Pharma opens new cGMP production line in India
The Mumbai-based company has installed a production line in Guwahati to enhance the manufacturing capacity of sterile products
Regulatory filing of tildrakizumab in Europe
Potential of tildrakizumab for patients with moderate-to-severe plaque psoriasis, without burden of frequent injections
Finance
Almirall pays Sun Pharma $50 million upfront in licensing deal for psoriasis treatment in Europe
Phase III clinical trials of tildrakizumab were completed in May, with positive results
Subscribe now